跳至主要内容
临床试验/NCT00693420
NCT00693420已完成3 期

Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence

Allergan0 个研究点目标入组 278 人开始时间: 2007年4月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
发起方
Allergan
入组人数
278
主要终点
Percentage of Participants Experiencing at Least a 1-grade Increase on the Global Eyelash Assessment (GEA) Scale From Baseline to Week 20 (Post-treatment)

研究概览

简要总结

This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Dissatisfaction with eyelash prominence,
  • Eyelash prominence assessment of minimal or moderate,
  • Ability to provide written informed consent

排除标准

  • Subjects without visible lashes,
  • Asymmetrical (uneven lashes or longer on one side than the other) eyelashes,
  • Any eye disease or abnormality,
  • Eye surgery,
  • Permanent eyeliner,
  • Eyelash implants,
  • Eyelash extension application,
  • Any use of eyelash growth products within 6 months of study entry,
  • Treatments that may effect hair growth,
  • Subjects requiring eye drop medications for glaucoma,
  • Subjects having a situation or condition, which the study doctor feels might put you at risk, may make the study results confusing, or may interfere with the study.

研究组 & 干预措施

1

Experimental

Bimatoprost 0.03% solution

干预措施: Bimatoprost 0.03% sterile solution (Drug)

2

Placebo Comparator

Vehicle solution

干预措施: vehicle sterile solution (Drug)

结局指标

主要结局

Percentage of Participants Experiencing at Least a 1-grade Increase on the Global Eyelash Assessment (GEA) Scale From Baseline to Week 20 (Post-treatment)

时间窗: Baseline to Week 20

The GEA scale is an investigator-graded 4-point ordinal scale of overall eyelash prominence (1 \[minimal\], 2 \[moderate\], 3 \[marked\], 4 \[very marked\])

Percentage of Participants Experiencing at Least a 1-grade Increase on the Global Eyelash Assessment (GEA) Scale From Baseline to Week 16

时间窗: Baseline to Week 16

The GEA scale is an investigator-graded 4-point ordinal scale of overall eyelash prominence (1 \[minimal\], 2 \[moderate\], 3 \[marked\], 4 \[very marked\])

次要结局

  • Upper Eyelash Length as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 16(Baseline to Week 16)
  • Upper Eyelash Length as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 20 (Post-treatment)(Baseline to Week 20)
  • Upper Eyelash Thickness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 16(Baseline to Week 16)
  • Upper Eyelash Thickness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 20 (Post-treatment)(Baseline to Week 20)
  • Upper Eyelash Darkness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 16(Baseline to Week 16)
  • Upper Eyelash Darkness as Measured by Digital Image Analysis in Terms of Change From Baseline to Week 20 (Post-treatment)(Baseline to Week 20)

研究者

发起方
Allergan
申办方类型
Industry

相似试验

Safety and Efficacy of Bimatoprost Solution in... | 临床试验